James Sabry at #JPM24 (Brian Benton Photography)
August 21, 2024 02:59 PM EDT
People
Pharma

Bio­Marin shakes up ex­ec­u­tive team, tap­ping no­table deal­mak­er James Sabry

Nicole DeFeudis

Editor

Bio­Marin is bring­ing promi­nent deal­mak­er James Sabry on­to its ex­ec­u­tive team, along with Am­gen rare dis­ease vet­er­an Greg Friberg.

Sabry will start on Oct. 7 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times